Predictive role of Apparent Diffusion Coefficient (ADC) from Diffusion Weighted MRI in patients with sacral chordoma treated with carbon ion radiotherapy (CIRT) alone.
Adult
Aged
Aged, 80 and over
Chordoma
/ diagnostic imaging
Diffusion Magnetic Resonance Imaging
/ methods
Female
Heavy Ion Radiotherapy
/ methods
Humans
Male
Middle Aged
Predictive Value of Tests
Retrospective Studies
Sacrum
/ diagnostic imaging
Spinal Neoplasms
/ diagnostic imaging
Treatment Outcome
Chordoma
Diffusion magnetic resonance imaging
Heavy ion radiotherapy
Journal
European journal of radiology
ISSN: 1872-7727
Titre abrégé: Eur J Radiol
Pays: Ireland
ID NLM: 8106411
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
received:
05
09
2019
revised:
23
02
2020
accepted:
01
03
2020
pubmed:
15
3
2020
medline:
1
12
2020
entrez:
15
3
2020
Statut:
ppublish
Résumé
To evaluate if baseline ADC from DWI sequences could predict response to treatment in patients with sacral chordoma not suitable for surgery treated with carbon ion radiotherapy (CIRT) alone compared with volume changes. Fifty-nine patients with sacral chordoma not suitable for surgery underwent one cycle of CIRT alone and a minimum of 12-months follow-up. All patients underwent MRI before treatment (baseline), every three months in the first two years after treatment, and every six months afterwards. For each MRI, lesion volume was obtained and median, kurtosis, and skewness ADC were analyzed within the whole lesion volume. Volume changes between baseline and the last available follow-up were used to divide patients with partial response, progression of disease and stable disease (PR, PD, and SD). Ten patients were excluded since DWI sequences from baseline MRI were not available. ADC maps obtained from baseline DWI examinations of 50 lesions in the remaining 49 patients were considered. Seven lesions were categorized as PD, 30 PR, and 13 SD. PD showed significantly higher median ADC values at baseline (p = 0.003) compared with both PR and SD (1665vs1253vs1263 *10 Preliminary results suggest that baseline ADC could predict response to treatment with CIRT, particularly to detect potential non-responder patients.
Identifiants
pubmed: 32171109
pii: S0720-048X(20)30122-4
doi: 10.1016/j.ejrad.2020.108933
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
108933Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest None.